Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Carcinoma, Ovarian Epithelial × Nivolumab × Clear all

Phase

Status

Active not recruiting 3 Terminated 2 Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 22 Carcinoma, Non-Small-Cell Lung 22 Stomach Neoplasms 8 Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Hepatocellular 6 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Hodgkin Disease 4 Urinary Bladder Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Uveal Melanoma 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Mesothelioma, Malignant 2 Lymphoma, B-Cell 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Merkel Cell 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Thymoma 1

Interventions

Carboplatin 15 Paclitaxel 13 olaparib 4 Hyperthermic Intraperitoneal Chemotherapy 4 Cisplatin 4 oregovomab 3 Topotecan 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 Amplified Fragment Length Polymorphism Analysis 3 niraparib 2 liposomal doxorubicin 2 ST 1481 2 Radiotherapy 2 Neoadjuvant Therapy 2 Immunohistochemistry 2 Gene Expression Profiling 2 Flow Cytometry 2 Drug Therapy 2 Diathermy 2 Cytoreduction Surgical Procedures 2 Bevacizumab 2 squalamine lactate 1 sodium sulfate 1 poly ICLC 1 pembrolizumab 1 pamiparib 1 mirvetuximab soravtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04620954 2021-12-01

ORION-02

National Cancer Centre, Singapore

Phase 1/2 Unknown

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡